Development of a hybrid bone substitute with cryopreserved auto stem cell (human bone marrow derived mesenchymal stem cell)

开发冷冻自体干细胞(人骨髓间充质干细胞)混合骨替代物

基本信息

  • 批准号:
    16592018
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

We established methods of isolating, proliferating and freezing human bone marrow-derived mesenchymal stem cells (hMSCs) and prepared hybrid-type bone substitute from the frozen hMSCs.[Experiments]1.Establishment of hMSC culture in human serum and preparation of scaffold1)Comparison of cell chemistry (alkaline phosphatase activity and Ca levels) between hMSCs cultured with human serum and those cultured with bovine serum2)Establishment of scaffold : Comparison of osteogenic potential in vivo among 3 different porous hydroxyapatite scaffolds2.Establishment of method for proliferating and inducing osteogenic differentiation from hMSCs : hMSCs were expanded in the presence of bFGF, and then cultured in the osteogenic medium(with and without glycerophosphate) to induce differentiation.1)In vitro : Cell chemistry(alkaline phosphatase activity and Ca levels in osteoblast cells)2)In vivo : Viability of bone tissues3)Freezing of proliferated hMSCs3.Preparation of hybrid-type bone substituteThe frozen hMSCs were cultured in the osteogenic medium(αMEM medium containing ascorbic acid, dexamethasone and glycerophosphate) to induce differentiation into osteogenic cell. Then, the hMCSs were seeded onto a porous hydroxyapatite to form hybrid-type bone substitute, which was implanted to nude mice to examine bone tissue viability.[Results]1)There was no difference in cellular biochemical activity between hMSCs cultured with FBS and those with human serum.2)There was difference in osteogenetic potential in vivo among the 3 different scaffolds used.3)αMEM medium containing ascorbic acid, dexamethasone and glycerophosphate was superior as osteoegenic medium.4)Active osteogenesis was observed in vivo with the hybrid-type bone substitute prepared from the frozen hMCSs.[Discussion]The frozen hMSCs cultured in autologous serum showed osteogenic potential. The hMSCs may provide possibilities for use in clinical setting if the safety is confirmed.
我们建立了人骨髓间充质干细胞(hMSCs)的分离、增殖和冷冻方法,并将冷冻后的hMSCs制备杂交型骨代用品。人血清hMSC培养的建立及支架的制备1)人血清培养的hMSC与牛血清培养的hMSC细胞化学(碱性磷酸酶活性和钙水平)的比较2)支架的建立:3种不同多孔羟基磷灰石支架在体内成骨潜能的比较2。hMSCs增殖诱导成骨分化方法的建立:在bFGF存在下扩增hMSCs,然后在成骨培养基(含和不含甘油磷酸盐)中培养诱导分化。1)体外:细胞化学(成骨细胞碱性磷酸酶活性和钙水平)2)体内:骨组织活力3)增殖hmscs的冷冻将冷冻后的hMSCs在含抗坏血酸、地塞米松和甘油磷酸盐的αMEM成骨培养基中培养,诱导分化为成骨细胞。然后,将hMCSs植入多孔羟基磷灰石,形成混合型骨替代物,植入裸鼠体内,检测骨组织活力。[结果]1)胎牛血清培养的hMSCs与人血清培养的hMSCs细胞生化活性无差异。2) 3种不同支架的体内成骨潜能存在差异。3)含抗坏血酸、地塞米松和甘油磷酸盐的αMEM培养基成骨效果较好。4)冷冻hmcs制备的混合型骨替代物在体内观察到活性成骨。【讨论】自体血清中冷冻培养的hMSCs具有成骨潜能。如果安全性得到证实,hMSCs可能会为临床应用提供可能性。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
口腔外科および形成外科的立場から見た顎矯正手術
从口腔外科和整形外科角度看正颌手术
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kasai K.;Fukawa T.;Yamazaki Y.;Tetsuya Oshikawa;Ai Suga A;Nianhui Cui;Yamazaki Y;Takayuki Tada;Takaaki Sagawa;山崎安晴
  • 通讯作者:
    山崎安晴
The Effect of Preoperative Use of Orthopedic Plate on the Articulatory Function in Children with Cleft Lip and Palate
术前使用矫形钢板对唇腭裂患儿关节功能的影响
A case report of maxillary protrution treated with maxillary anterior alveolar osteotomy and genioplasty.
上颌前牙槽截骨加颏成形术治疗上颌前突一例报告.
人工口蓋床と術後構音
人工腭底及术后关节
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    鈴木恵子;山崎安晴;瀬崎晃一郎;内沼栄樹
  • 通讯作者:
    内沼栄樹
Cleft lip/palate, and alveolar bone graft
唇裂/腭裂和牙槽骨移植
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAZAKI Yasuharu其他文献

YAMAZAKI Yasuharu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAZAKI Yasuharu', 18)}}的其他基金

Possibility of bone substitute by using tissue engineering, concerning the bone grafting operation to the alveolar cleft of CL/CP.
组织工程骨替代的可能性,关于CL/CP牙槽裂的植骨手术。
  • 批准号:
    23592942
  • 财政年份:
    2011
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The cryopreservation of umbilical cord blood derived mesenchymal stem cells and the possibility of clinical application of those cells to cleft lip and palate patient.
脐带血间充质干细胞的冷冻保存及其临床应用于唇腭裂患者的可能性。
  • 批准号:
    20592345
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quality and safety of cryopreserved human mesenchymal stem cell(MSC) during serial subculture
连续传代培养中冻存人间充质干细胞(MSC)的质量和安全性
  • 批准号:
    18592198
  • 财政年份:
    2006
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Biological viability of the bone marrow stem cell cultured from bone disease patients
从骨病患者体内培养的骨髓干细胞的生物学活性
  • 批准号:
    12671961
  • 财政年份:
    2000
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Epidemiological study and candidate gene analysis of cleft lip and /or plate in Japanese patients
日本唇裂和/或板裂患者流行病学研究及候选基因分析
  • 批准号:
    10671903
  • 财政年份:
    1998
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Development of Bone Substitute Added with Bone Morphogenetic Protein and Clinical Application
添加骨形态发生蛋白的骨替代品的研制及临床应用
  • 批准号:
    01870086
  • 财政年份:
    1989
  • 资助金额:
    $ 1.92万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B).
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了